ImageneBio, Inc. Common Stock

IMANASDAQ • USD
4.70 USD
↗ 0.10 (2.07%)🟢LIVE (AS OF 03:09 PM EDT)
🟢Market: OPEN

Shares of ImageneBio, Inc. Common Stock (IMA) are trading at $4.70. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$4.61
High?$4.81
Low?$4.44
Prev. Close?$4.60
Volume?1.5K
Avg. Volume?15.8K
VWAP?$4.69
Rel. Volume?0.10x
Bid / Ask
Bid?$3.95 × 100
Ask?$5.44 × 100
Spread?$1.49
Midpoint?$4.70
Valuation & Ratios
Market Cap?52.2M
Shares Out?11.4M
Float?9.4M
Float %?83.2%
P/E Ratio?N/A
P/B Ratio?0.37
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
18
Market Cap
52.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
6
Momentum?
50
Short Sent.?
69
Piotroski F-Score?0/9Weak
Altman Z-Score?0.61Distress
Confidence?28%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.37%Low
Short Interest?34.6K
Days to Cover?2.3
Free Float9.4M
Avg Daily Volume15.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?21.47Strong
Quick Ratio?21.47Strong
Cash Ratio?14.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.37CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-37.5%WEAK▾
ROA?
S&P
3
-35.1%WEAK▾
Cash Flow & Enterprise
FCF?$-57733000
Enterprise Value?$-42460302
Fundamentals ratios updated end of day